427 related articles for article (PubMed ID: 36268851)
1. A study of the molecular mechanism of quercetin and dasatinib combination as senolytic in alleviating age-related and kidney diseases.
Alharbi KS; Afzal O; Altamimi ASA; Almalki WH; Kazmi I; Al-Abbasi FA; Alzarea SI; Makeen HA; Albratty M
J Food Biochem; 2022 Dec; 46(12):e14471. PubMed ID: 36268851
[TBL] [Abstract][Full Text] [Related]
2. Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans.
Zhu Y; Prata LGPL; Gerdes EOW; Netto JME; Pirtskhalava T; Giorgadze N; Tripathi U; Inman CL; Johnson KO; Xue A; Palmer AK; Chen T; Schaefer K; Justice JN; Nambiar AM; Musi N; Kritchevsky SB; Chen J; Khosla S; Jurk D; Schafer MJ; Tchkonia T; Kirkland JL
EBioMedicine; 2022 Mar; 77():103912. PubMed ID: 35292270
[TBL] [Abstract][Full Text] [Related]
3. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease.
Hickson LJ; Langhi Prata LGP; Bobart SA; Evans TK; Giorgadze N; Hashmi SK; Herrmann SM; Jensen MD; Jia Q; Jordan KL; Kellogg TA; Khosla S; Koerber DM; Lagnado AB; Lawson DK; LeBrasseur NK; Lerman LO; McDonald KM; McKenzie TJ; Passos JF; Pignolo RJ; Pirtskhalava T; Saadiq IM; Schaefer KK; Textor SC; Victorelli SG; Volkman TL; Xue A; Wentworth MA; Wissler Gerdes EO; Zhu Y; Tchkonia T; Kirkland JL
EBioMedicine; 2019 Sep; 47():446-456. PubMed ID: 31542391
[TBL] [Abstract][Full Text] [Related]
4. Senolytic drugs dasatinib and quercetin combined with Carboplatin or Olaparib reduced the peritoneal and adipose tissue metastasis of ovarian cancer.
Wang L; Xiong B; Lu W; Cheng Y; Zhu J; Ai G; Zhang X; Liu X; Cheng Z
Biomed Pharmacother; 2024 May; 174():116474. PubMed ID: 38518604
[TBL] [Abstract][Full Text] [Related]
5. Senolytic Combination of Dasatinib and Quercetin Alleviates Intestinal Senescence and Inflammation and Modulates the Gut Microbiome in Aged Mice.
Saccon TD; Nagpal R; Yadav H; Cavalcante MB; Nunes ADC; Schneider A; Gesing A; Hughes B; Yousefzadeh M; Tchkonia T; Kirkland JL; Niedernhofer LJ; Robbins PD; Masternak MM
J Gerontol A Biol Sci Med Sci; 2021 Oct; 76(11):1895-1905. PubMed ID: 33406219
[TBL] [Abstract][Full Text] [Related]
6. Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age.
Islam MT; Tuday E; Allen S; Kim J; Trott DW; Holland WL; Donato AJ; Lesniewski LA
Aging Cell; 2023 Feb; 22(2):e13767. PubMed ID: 36637079
[TBL] [Abstract][Full Text] [Related]
7. Cellular Senescence and Senolytic Agents: Recent Updates on Their Role and Applications.
Chandrakar L; Ambatwar R; Khatik GL
Curr Top Med Chem; 2024; 24(2):157-178. PubMed ID: 38037999
[TBL] [Abstract][Full Text] [Related]
8. Short senolytic or senostatic interventions rescue progression of radiation-induced frailty and premature ageing in mice.
Fielder E; Wan T; Alimohammadiha G; Ishaq A; Low E; Weigand BM; Kelly G; Parker C; Griffin B; Jurk D; Korolchuk VI; von Zglinicki T; Miwa S
Elife; 2022 May; 11():. PubMed ID: 35507395
[TBL] [Abstract][Full Text] [Related]
9. The Achilles' heel of senescent cells: from transcriptome to senolytic drugs.
Zhu Y; Tchkonia T; Pirtskhalava T; Gower AC; Ding H; Giorgadze N; Palmer AK; Ikeno Y; Hubbard GB; Lenburg M; O'Hara SP; LaRusso NF; Miller JD; Roos CM; Verzosa GC; LeBrasseur NK; Wren JD; Farr JN; Khosla S; Stout MB; McGowan SJ; Fuhrmann-Stroissnigg H; Gurkar AU; Zhao J; Colangelo D; Dorronsoro A; Ling YY; Barghouthy AS; Navarro DC; Sano T; Robbins PD; Niedernhofer LJ; Kirkland JL
Aging Cell; 2015 Aug; 14(4):644-58. PubMed ID: 25754370
[TBL] [Abstract][Full Text] [Related]
10. Targeting Cellular Senescence for Age-Related Diseases: Path to Clinical Translation.
Wyles SP; Tchkonia T; Kirkland JL
Plast Reconstr Surg; 2022 Oct; 150():20S-26S. PubMed ID: 36170432
[TBL] [Abstract][Full Text] [Related]
11. Mild exacerbation of obesity- and age-dependent liver disease progression by senolytic cocktail dasatinib + quercetin.
Raffaele M; Kovacovicova K; Frohlich J; Lo Re O; Giallongo S; Oben JA; Faldyna M; Leva L; Giannone AG; Cabibi D; Vinciguerra M
Cell Commun Signal; 2021 Apr; 19(1):44. PubMed ID: 33832488
[TBL] [Abstract][Full Text] [Related]
12. Quercetin and dasatinib, two powerful senolytics in age-related cardiovascular disease.
Nieto M; Konigsberg M; Silva-Palacios A
Biogerontology; 2024 Feb; 25(1):71-82. PubMed ID: 37747577
[TBL] [Abstract][Full Text] [Related]
13. Senolytic treatment reverses obesity-mediated senescent cell accumulation in the ovary.
Hense JD; Garcia DN; Isola JV; Alvarado-Rincón JA; Zanini BM; Prosczek JB; Stout MB; Mason JB; Walsh PT; Brieño-Enríquez MA; Schadock I; Barros CC; Masternak MM; Schneider A
Geroscience; 2022 Jun; 44(3):1747-1759. PubMed ID: 35460445
[TBL] [Abstract][Full Text] [Related]
14. Natural Products as a Major Source of Candidates for Potential Senolytic Compounds obtained by
Barrera-Vázquez OS; Magos-Guerrero GA; Escobar-Ramírez JL; Gomez-Verjan JC
Med Chem; 2023; 19(7):653-668. PubMed ID: 36278464
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological Targeting of Senescence with Senolytics as a New Therapeutic Strategy for Neurodegeneration.
Richardson M; Richardson DR
Mol Pharmacol; 2024 Jan; 105(2):64-74. PubMed ID: 38164616
[TBL] [Abstract][Full Text] [Related]
16. Wnt/β-catenin/RAS signaling mediates age-related renal fibrosis and is associated with mitochondrial dysfunction.
Miao J; Liu J; Niu J; Zhang Y; Shen W; Luo C; Liu Y; Li C; Li H; Yang P; Liu Y; Hou FF; Zhou L
Aging Cell; 2019 Oct; 18(5):e13004. PubMed ID: 31318148
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors.
Zhu Y; Tchkonia T; Fuhrmann-Stroissnigg H; Dai HM; Ling YY; Stout MB; Pirtskhalava T; Giorgadze N; Johnson KO; Giles CB; Wren JD; Niedernhofer LJ; Robbins PD; Kirkland JL
Aging Cell; 2016 Jun; 15(3):428-35. PubMed ID: 26711051
[TBL] [Abstract][Full Text] [Related]
18. Identification of gingerenone A as a novel senolytic compound.
Moaddel R; Rossi M; Rodriguez S; Munk R; Khadeer M; Abdelmohsen K; Gorospe M; Ferrucci L
PLoS One; 2022; 17(3):e0266135. PubMed ID: 35349590
[TBL] [Abstract][Full Text] [Related]
19. Targeting senescent cells alleviates obesity-induced metabolic dysfunction.
Palmer AK; Xu M; Zhu Y; Pirtskhalava T; Weivoda MM; Hachfeld CM; Prata LG; van Dijk TH; Verkade E; Casaclang-Verzosa G; Johnson KO; Cubro H; Doornebal EJ; Ogrodnik M; Jurk D; Jensen MD; Chini EN; Miller JD; Matveyenko A; Stout MB; Schafer MJ; White TA; Hickson LJ; Demaria M; Garovic V; Grande J; Arriaga EA; Kuipers F; von Zglinicki T; LeBrasseur NK; Campisi J; Tchkonia T; Kirkland JL
Aging Cell; 2019 Jun; 18(3):e12950. PubMed ID: 30907060
[TBL] [Abstract][Full Text] [Related]
20. Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice.
Roos CM; Zhang B; Palmer AK; Ogrodnik MB; Pirtskhalava T; Thalji NM; Hagler M; Jurk D; Smith LA; Casaclang-Verzosa G; Zhu Y; Schafer MJ; Tchkonia T; Kirkland JL; Miller JD
Aging Cell; 2016 Oct; 15(5):973-7. PubMed ID: 26864908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
